戻る
Xilio Therapeutics Inc (XLO)価格
XLO 株価推移チャート
XLO 収入
Xilio Therapeutics Inc
$0.64
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.64
0.6%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.6401
始値
$0.65
当日レンジ
$0.6341 - $0.65
52週レンジ
$0.615 - $1.7
取引高
128.1K
平均取引高
616.1K
1株当たり利益(TTM)
-0.66
配当利回り
--
時価総額
$33.8M
XLOとは何ですか？
Xilio Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Waltham, Massachusetts and currently employs 64 full-time employees. The company went IPO on 2021-10-22. The firm is engaged in discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to build a pipeline of novel, tumor-activated I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines, antibodies, bispecific and immune cell engagers. Its pipeline products include Vilastobart (XTX101), XTX301, XTX501, and tumor-activated bispecific molecules and immune cell-engaging molecules. XTX101 is an investigational tumor-activated, Fc-enhanced, high-affinity binding anti-CTLA-4 monoclonal antibody. XTX301, a tumor-activated, engineered interleukin 12, or IL-12, therapy.